These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 4407412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.
    Henning M, Rubenson A.
    J Pharm Pharmacol; 1970 Mar; 22(3):241-3. PubMed ID: 4399501
    [No Abstract] [Full Text] [Related]

  • 4. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S.
    Brain Res; 1974 Mar 29; 69(1):57-65. PubMed ID: 4150408
    [No Abstract] [Full Text] [Related]

  • 5. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y, Wepierre J, Jacquot C, Rapin J.
    Arch Int Pharmacodyn Ther; 1974 Feb 29; 207(2):348-60. PubMed ID: 4827419
    [No Abstract] [Full Text] [Related]

  • 6. Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
    Vazquez AJ, Sabelli HC.
    Exp Neurol; 1975 Jan 29; 46(1):44-56. PubMed ID: 1109342
    [No Abstract] [Full Text] [Related]

  • 7. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE, Moore KE.
    Arch Int Pharmacodyn Ther; 1971 Nov 29; 194(1):158-67. PubMed ID: 4399378
    [No Abstract] [Full Text] [Related]

  • 8. Photic evoked cortical potentials: interaction of reserpine, monoamine oxidase inhibition, and DOPA.
    Sabelli HC, Giardina WJ, Bartizal F.
    Biol Psychiatry; 1971 Nov 29; 3(3):273-80. PubMed ID: 5163812
    [No Abstract] [Full Text] [Related]

  • 9. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A, Jenner P, Marsden CD.
    Br J Pharmacol; 1975 Jun 29; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI, Uretsky NJ.
    J Pharmacol Exp Ther; 1973 Sep 29; 186(3):616-24. PubMed ID: 4728340
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor.
    Ishii Y, Natsugoe K, Umezawa H.
    Arzneimittelforschung; 1975 Feb 29; 25(2):213-5. PubMed ID: 1173034
    [Abstract] [Full Text] [Related]

  • 12. Copulatory behavior in the male rat after impaired monoaminergic neurotransmission.
    Malmnäs CO.
    Acta Physiol Scand Suppl; 1973 Feb 29; 400():69-95. PubMed ID: 4136131
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML, Lotti VJ, Clark CM, Stone CA.
    Arch Int Pharmacodyn Ther; 1973 Sep 29; 205(1):103-13. PubMed ID: 4148405
    [No Abstract] [Full Text] [Related]

  • 14. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ, Littleton JM, Oritz A, Brownlee G.
    Br J Pharmacol; 1973 Jun 29; 48(2):354P. PubMed ID: 4147432
    [No Abstract] [Full Text] [Related]

  • 15. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J, Reichenberg K, wiszniowska G, Marchaj J.
    Pol J Pharmacol Pharm; 1973 Jun 29; 25(6):559-72. PubMed ID: 4792476
    [No Abstract] [Full Text] [Related]

  • 16. [Role of dopamine and noradrenaline in altering direct cortical response under the action of fenamin? phenamine?].
    Il'iuchenok RIu, Martynov NN.
    Farmakol Toksikol; 1974 Jun 29; 37(6):655-8. PubMed ID: 4464087
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
    Korduba CA, Veals J, Symchowicz S.
    J Pharmacol Exp Ther; 1974 Sep 29; 190(3):459-65. PubMed ID: 4413186
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of the functional roles of norepinephrine, dopamine, and phenylethylamine in the central nervous system.
    Sabelli HC, Giardina WJ, Mosnaim AD, Sabelli NH.
    Acta Physiol Pol; 1973 Sep 29; 24(1):33-40. PubMed ID: 4716347
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of the anticonvulsant activity of L-dopa by FLA-63, a dopamine- -hydroxylase inhibitor.
    McKenzie GM, Soroko FE.
    J Pharm Pharmacol; 1973 Jan 29; 25(1):76-7. PubMed ID: 4146205
    [No Abstract] [Full Text] [Related]

  • 20. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH, Szczypka MS, Palmiter RD, Dorsa DM.
    Brain Res; 2004 Oct 01; 1022(1-2):71-80. PubMed ID: 15353215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.